SBI Life Insurance Share Price Target at Rs 2,350: Axis Securities
Axis Securities has reiterated a Buy rating on SBI Life Insurance Limited, setting a target price of Rs 2,350, implying a 27% upside from the current market price of Rs 1,859. The brokerage's July 27 result update shows SBI Life beat estimates across new business premium, annualized premium equivalent and value of new business in the June quarter. Value of new business climbed 29% year-on-year to Rs 14.1 billion, with margins holding at 26.2%, temporarily dented by a lumpy group-business mix and residual GST effects. Distribution diversification through an expanding agency network, alongside resilient bancassurance contribution, continues to anchor the insurer's growth outlook into FY27.
Axis Securities Backs SBI Life With Buy Call, Rs 2,350 Target as Agency Push Offsets Margin Wobble
Q1FY27 update flags 29% VNB growth, a widening agency franchise and a temporary persistency dip in policies dating to the pandemic years.
The Headline Numbers
Axis Securities' Q1FY27 result update on SBI Life Insurance Ltd. records a clean sweep on all three headline metrics, with new business premium, annualized premium equivalent and value of new business each landing ahead of the brokerage's own forecasts.
- Gross written premium touched Rs 212.9 billion, a 4% beat against estimates and up 20% year-on-year.
- Annualized premium equivalent rose 36% year-on-year to Rs 53.8 billion, aided by an unusually strong group-business quarter.
- Value of new business advanced 29% year-on-year to Rs 14.1 billion, a 5.5% beat versus Axis Securities' own projection.
- Value of new business margin held at 26.2%; stripped of a residual goods and services tax drag, the brokerage calculates the underlying figure at 27.4%.
Agency Channel Does the Heavy Lifting
The report's central thesis is one of distribution diversification. SBI Life added 34,000 agents during the quarter under its Agency 2.0 and Agency Next initiatives, and the channel delivered 20% year-on-year growth in individual annualized premium equivalent. That expansion is gradually rebalancing a book long dominated by the insurer's bancassurance tie-up with State Bank of India.
The SBI and regional rural bank bancassurance channel still contributed 47% of total annualized premium equivalent, with individual premium in that channel growing 10% year-on-year and branch productivity improving 7%. Non-SBI bank partnerships, including a newly added tie-up with J&K Bank, grew a faster 19% year-on-year, a trend management expects to continue supporting incremental volumes.
Protection sales stood out within the mix: protection new business premium roughly doubled to Rs 19.6 billion from Rs 9.8 billion a year earlier, lifting protection's share of total new business premium to 22%. Management also flagged a shift within that segment away from return-of-premium products, whose share fell to 68% from 73%, toward higher-margin pure protection covers, which grew 41% year-on-year.
"Management indicated that Q1 marks the trough for value-of-new-business margins, with the metric expected to improve through the remaining quarters and trend toward the upper end of the 26–28% guided range for the full year," the Axis Securities update states, attributing the improvement path to a normalizing group-business mix and continued growth in protection and non-participating products.
Persistency: Mostly Improving, One Soft Spot
Customer retention metrics were broadly positive, with two of three tracked cohorts improving and one flagged as a temporary anomaly.
| Persistency Cohort | Q1FY27 | Q1FY26 | Change |
|---|---|---|---|
| 13th month | 87.7% | 87.1% | +58 bps |
| 37th month | 72.4% | 72.0% | +44 bps |
| 61st month | 58.4% | 62.8% | -440 bps |
Axis Securities attributes the 61st-month weakness entirely to pandemic-era policies moving through the persistency cycle, an effect management expects to normalize by the end of FY27.
Cost Pressures Are Structural, Not Transient
The opex ratio widened to 7.7% from 6.3% a year earlier, and the total cost ratio rose to 12.0% from 10.8%. Two drivers stand out: higher stamp duty tied to a 46% jump in individual sum assured, reflecting the shift toward protection products, and the first-time impact of labour-code-related employee costs. Management does not expect this to ease — the report notes the elevated cost trajectory is "structural and likely to persist through FY27," with expenses tracking sum-assured growth.
Estimates and Valuation
Axis Securities trimmed its target price marginally, to Rs 2,350 from Rs 2,440 previously, even as it nudged estimates higher, valuing the insurer at 2.1x FY28E embedded value against a current multiple of 1.7x.
| Metric (Rs Bn) | FY26 | FY27E | FY28E |
|---|---|---|---|
| New Business Premium | 425.5 | 476.7 | 553.2 |
| Value of New Business | 66.7 | 74.5 | 85.4 |
| PAT | 24.7 | 28.4 | 37.6 |
| Embedded Value | 807.9 | 952.8 | 1,121.0 |
| P/EV (x) | 2.3 | 2.0 | 1.7 |
The brokerage projects a healthy 14% new business premium, 14% annualized premium equivalent and 13% value-of-new-business CAGR over FY26–28. Management has reiterated FY27 individual rated premium growth guidance of 14-15%.
Levels for Investors
| Level | Price (Rs) |
|---|---|
| 52-Week High | 2,133 |
| 52-Week Low | 1,702 |
| Current Market Price | 1,859 |
| Target Price (Buy) | 2,350 |
Key Risk
Axis Securities flags a single primary risk to its target: a slowdown in annualized premium equivalent growth or an unfavorable shift in product mix, either of which could pressure value-of-new-business margins and, by extension, the brokerage's estimates.
Sources & Disclosures
This report draws on a Result Update on SBI Life Insurance Ltd. published by Axis Securities Research (Axis Direct), dated July 27, 2026, along with the company's Q1FY27 financial disclosures.
Market risk disclaimer: Investments in securities markets are subject to market risk. Brokerage ratings, price targets and earnings estimates reflect the analysts' views at the time of publication and are not a guarantee of future performance. Readers should conduct independent due diligence or consult a qualified financial adviser before making investment decisions.
